Sherbrooke Park Advisers LLC Inogen Inc Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Inogen Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 59,069 shares of INGN stock, worth $568,834. This represents 0.13% of its overall portfolio holdings.
Number of Shares
59,069
Previous 14,027
321.11%
Holding current value
$568,834
Previous $114 Million
402.43%
% of portfolio
0.13%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding INGN
# of Institutions
143Shares Held
21MCall Options Held
119KPut Options Held
149K-
Camber Capital Management LP Boston, MA2MShares$19.3 Million0.62% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$15.7 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.56MShares$15 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$14.4 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.06MShares$10.2 Million1.38% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $220M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...